Eltroxin 100 microgram Tablets
*Company:
ADVANZ PharmaStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 22 December 2023
File name
100mcg SPC IE.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 December 2023
File name
100mcg PIL IE.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - marketing authorisation holder
Updated on 05 August 2022
File name
Levothyroxine sodium Tablet 100 mcg Eltroxin_PA1142028002-IE_SmPC.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 05 August 2022
File name
Levothyroxine sodium Tablet 100 mcg Eltroxin_PA1142028002-IE_PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children and adolescents
- Change to section 2 - excipient warnings
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 28 February 2022
File name
ELTROXIN_Levothyroxine sodium Tablet 100mcg _SPC_IE.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Approved test procedure for related substances and reduction in shelf life of finished product
Updated on 14 March 2021
File name
ie-spc.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
update to safety and efficacy information as per HPRA instruction
Updated on 14 March 2021
File name
ie-pil.pdf
Reasons for updating
- New PIL for new product
Updated on 11 April 2019
File name
190405-SPC-100.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
ADVANZ Pharma
Address:
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United KingdomMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230